Your browser doesn't support javascript.
loading
The impact of SARS-CoV-2 on the cystic fibrosis foundation therapeutics development network.
Pearson, Kelsie; Mayer-Hamblett, Nicole; Goss, Christopher H; Retsch-Bogart, George Z; VanDalfsen, Jill M; Burks, Patricia; Rosenbluth, Daniel; Clancy, John Paul; Hoffman, Amy; Nichols, David P.
Afiliação
  • Pearson K; Cystic Fibrosis Foundation Therapeutics Development Network Coordinating Center, Seattle Children's Hospital, Seattle, WA, United States. Electronic address: kelsie.pearson@seattlechildrens.org.
  • Mayer-Hamblett N; Cystic Fibrosis Foundation Therapeutics Development Network Coordinating Center, Seattle Children's Hospital, Seattle, WA, United States; Department of Pediatrics, University of Washington, Seattle, WA, United States; Department of Biostatistics, University of Washington, Seattle, WA, United States.
  • Goss CH; Cystic Fibrosis Foundation Therapeutics Development Network Coordinating Center, Seattle Children's Hospital, Seattle, WA, United States; Department of Medicine, University of Washington, Seattle, WA, United States.
  • Retsch-Bogart GZ; Division of Pediatric Pulmonology, University of North Carolina, Chapel Hill, NC, United States.
  • VanDalfsen JM; Cystic Fibrosis Foundation Therapeutics Development Network Coordinating Center, Seattle Children's Hospital, Seattle, WA, United States.
  • Burks P; Cystic Fibrosis Foundation, Bethesda, MD, United States.
  • Rosenbluth D; Division of Pulmonary and Critical Care Medicine, Washington University School of Medicine, St Louis, Missouri, United States.
  • Clancy JP; Cystic Fibrosis Foundation, Bethesda, MD, United States.
  • Hoffman A; Cystic Fibrosis Foundation Therapeutics Development Network Coordinating Center, Seattle Children's Hospital, Seattle, WA, United States.
  • Nichols DP; Cystic Fibrosis Foundation Therapeutics Development Network Coordinating Center, Seattle Children's Hospital, Seattle, WA, United States; Department of Pediatrics, University of Washington, Seattle, WA, United States.
J Cyst Fibros ; 20(2): 195-197, 2021 03.
Article em En | MEDLINE | ID: mdl-33349583
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fibrose Cística / Pesquisa Biomédica / COVID-19 Limite: Humans Idioma: En Revista: J Cyst Fibros Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fibrose Cística / Pesquisa Biomédica / COVID-19 Limite: Humans Idioma: En Revista: J Cyst Fibros Ano de publicação: 2021 Tipo de documento: Article